Bank of New Hampshire’s AbbVie ABBV Stock Holding History

Bank of New Hampshire’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.73M	Sell	14,813 -274	-2%	-$59K	0.78%	37
2026 Q1	$3.28M	Buy	15,087 +350	+2%	+$77.6K	0.75%	35
2025 Q4	$3.37M	Sell	14,737 -5	-0%	-$1.14K	0.76%	36
2025 Q3	$3.41M	Sell	14,742 -165	-1%	-$33.6K	0.79%	31
2025 Q2	$2.77M	Sell	14,907 -856	-5%	-$159K	0.69%	45
2025 Q1	$3.3M	Sell	15,763 -389	-2%	-$75.6K	0.86%	36
2024 Q4	$2.87M	Sell	16,152 -658	-4%	-$121K	0.74%	40
2024 Q3	$3.32M	Sell	16,810 -302	-2%	-$56.4K	0.83%	37
2024 Q2	$2.94M	Sell	17,112 -1,648	-9%	-$273K	0.76%	37
2024 Q1	$3.42M	Sell	18,760 -447	-2%	-$77K	0.9%	31
2023 Q4	$2.98M	Sell	19,207 -7,211	-27%	-$1.05M	0.84%	33
2023 Q3	$3.94M	Sell	26,418 -152	-0.6%	-$22.3K	1.18%	22
2023 Q2	$3.58M	Buy	26,570 +64	+0.2%	+$9.38K	1.02%	28
2023 Q1	$4.22M	Sell	26,506 -610	-2%	-$93.3K	1.27%	19
2022 Q4	$4.38M	Sell	27,116 -1,802	-6%	-$276K	1.32%	18
2022 Q3	$3.88M	Sell	28,918 -221	-0.8%	-$31.7K	1.21%	20
2022 Q2	$4.46M	Sell	29,139 -1,391	-5%	-$213K	1.29%	19
2022 Q1	$4.95M	Buy	30,530 +123	+0.4%	+$17.9K	1.2%	20
2021 Q4	$4.12M	Sell	30,407 -5,047	-14%	-$596K	1%	30
2021 Q3	$3.99M	Hold	35,454	–	–	1.07%	25
2021 Q2	$3.99M	Buy	+35,454	New	+$3.99M	1.07%	25

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Bank of New Hampshire's ABBV Position: Q2 2026 in Review

Bank of New Hampshire reduced its AbbVie (ABBV) stake by 1.8% in Q2 2026, selling an estimated $59K and leaving 14,813 shares worth $3.73M. The position accounts for 0.78% of the portfolio, ranked #37.

Bank of New Hampshire first reported a position in ABBV in Q2 2021 and has held it in 21 quarters since. The position peaked at $4.95M in Q1 2022. 2,963 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Bank of New Hampshire held 14,813 shares of AbbVie worth $3.73M as of Q2 2026.
Bank of New Hampshire sold 274 AbbVie shares in Q2 2026, an estimated $59K.
AbbVie made up 0.78% of Bank of New Hampshire's portfolio in Q2 2026, its #37 holding.
Bank of New Hampshire first reported a position in AbbVie in Q2 2021 and has held it in 21 quarters since.
Bank of New Hampshire's AbbVie position peaked at $4.95M in Q1 2022.
2,963 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bank of New Hampshire's 13F filing for Q2 2026, filed 14 Jul 2026.